Submit manuscript...
MOJ
eISSN: 2574-9722

Biology and Medicine

Short Communication Volume 6 Issue 1

Immune response by the human body to SARS-CoV 2 infection

PD Gupta1

1Director Grade Scientist, Centre for Cellular and Molecular Biology), India
1Director Grade Scientist, Centre for Cellular and Molecular Biology), India

Correspondence: PD Gupta, Former, Director Grade Scientist, Centre for Cellular and Molecular Biology), Hyderabad, India

Received: December 01, 2020 | Published: February 8, 2021

Citation: Gupta PD. Immune response by the human body to SARS-CoV 2 infection. MOJ Biol Med. 2021;6(1):30-31. DOI: 10.15406/mojbm.2021.06.00125

Download PDF

Abstract

A new virus SARS-CoV2 is responsible for Covid-19. Many existing drugs were tried but failed to treat Covid-19 patients. To begin with our immune system also couldn’t cope with Covid-19, therefore within no time it became pandemic. It is a well-known fact that our body fights against all infections and inflammations through well-organized immune system. The human immune system is made up of individual cells (T and B cells) and proteins as well as entire organs and organ systems. The organs of the immune system include skin and mucous membranes, and the organs of the lymphatic system. The skin and mucous membranes are the first line of defense against germs entering from outside the body and once the infection enter in the organs and tissues lymphatic organs take over. Additionally, here we also described gut bacteria and food to build up immunity. In this way human beings are fight against the new virus SARS-CoV2 infections.

Introduction

The mucosal surfaces of the body are particularly vulnerable to infection. Most COVID-19 tests are based on nasal swabs or saliva samples that measure the amount of SARS-CoV-2 virus in the mouth or nose, it is important to understand how immunity to the virus develops in these mucous membranes.1 The mucosal immune system provides three main functions: serving as the body's first line defense from antigens and infection, preventing systemic immune responses to commensally bacteria and food antigens (primarily food proteins in the Gut-associated lymphoid tissue, so-called oral tolerance), and regulating. Nonspecific immunity (Innate immunity) is the defense system with which a child is born.2–5 It protects against all antigens. Innate immunity involves barriers that keep harmful materials from entering the body. These barriers form the first line of defense in the immune response. However, when the child reaches the age of 7 or 8, most of its immune system development is complete.

Cutaneous and Mucosal Immuno-protection

The body has devoiced to prevent by restricted entry of bacteria, viruses nfection including SARS-CoV 2 by Cutaneous and Mucosal Immuno-protection. It is clear that regional specialization of the immune system exists, and one such specialization is represented by skin-associated lymphoid tissue (SALT). The skin contains, especially within the epidermis, several important types of lymphoreticular cells whose interactions with antigens and with neighbouring keratinocytes lead to elaboration of antigenic signals that can be acted on by immunocompetent lymphocytes.6 SALT protects the body tracts and skin.7 The SALT consists of diffuse collections of innate leukocytes and T cells in the epidermis and dermis. Keratinocytes  provide an overlying physical barrier and secrete pro-inflammatory cytokines / chemokines that activate phagocytes and specialized antigen-presenting cells called Langerhans cells.6 Antigens are presented locally to activate epidermal  memory T cells  or are conveyed to  naïve T cells  in the local lymph node. Effector T cells generated can then home to skin sites under attack. While the skin is protected by Th1/Th17 responses initially,8 a persistent pathogen can trigger macrophage hyperactivation resulting in tissue damage.

Mucosal surfaces constitute a large host-environmental interface that must be protected from pathogenic organisms. The mucosal immune system1 has evolved as a distinct immune organ functioning independently from its systemic counterpart. The mucosal immune system has the difficult task of mounting protective responses to invading microorganisms while maintaining a state of non responsiveness to commensal bacteria and food antigens. The system has unique cellular components and functional aspects that permit it to carry out this dual role.9,10

The mucosa-associated lymphoid tissue (MALT) Anatomical barriers, secretory IgA  (SIgA), and innate  leukocytes provide initial defense in the MALT. M cells in the follicle-associated epithelium (FAE) of inductive sites capture pathogens and convey them to mucosal APCs and T cells in domes covering B cell-containing lymphoid follicles. DCs also capture antigen via transepithelial dendrites. Effector lymphocytes migrate to multiple mucosal effector sites to provide coordinated protection via the “common mucosal immune system.” Immune responses in the MALT are biased toward SIgA to reduce inflammatory damage to fragile mucosae11 however, aggressive pathogens trigger more inflammatory Th1/Th17 responses.8

Immuno-protection by the Gut

That is where most immune system cells are produced in the gut and then also multiply. These cells move to other organs and tissues through the blood. Healthy bacteria found in your gut is also used to stimulate the development of T‑cells, About 70 per­cent of the immune sys­tem is housed in the gut, .therefore the food and bev­er­ages one con­sumes, can also help sup­port the immune sys­tem to SARS-CoV 2 Infection. The gut microbiota influences development and homeostasis of the mammalian immune system, and is associated with human inflammatory and immune diseases. Healthy bac­te­ria found in the gut is also used to stim­u­late the devel­op­ment of T‑cells, which are respon­si­ble for dis­tin­guish­ing body’s cells and tis­sue from poten­tial­ly harm­ful things in the body.12 When there the is an imbal­ance in your gut, such as an over­growth of ​“bad” bac­te­ria, it can caus­e even cancer.13 This is why main­tain­ing the bal­ance and health of the diges­tive sys­tem is impor­tant.

Try adding fiber-rich foods to the diet such as fruits, grains, nuts and veg­eta­bles. Fiber helps to reg­u­late your diges­tive tract, pro­mote reg­u­lar bow­el move­ments and sup­port the good bac­te­ria in the gut. Foods that con­tain pro­bi­otics14 can also give boost to the health and prevent SARS-CoV 2 Infection. Pro­bi­otics are healthy bac­te­ria that work to break down fiber in your body, reduc­ing indi­ges­tion symp­toms includ­ing gas and bloat­ing. Pro­bi­otics are found in fer­ment­ed foods such as sauer­kraut and miso as well as yogurts con­tain­ing live and active cultures.

Acknowledgments

None.

Conflicts of interest

None.

Funding

None.

References

  1. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12( 5):383–390.
  2. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3(2):133–146.
  3. Olin, Axel, Henckel E, Yang C, et al. Stereotypic Immune System Development in Newborn Children. J Cell. 2018;174(5):1277–1292.e14.
  4. Gomez de Agüero MC, Ganal-Vonarburg S, Tobias F. et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351(6279):1296–1302.
  5. Gupta PD, Tyagi S. Development of Immune system from New born to Adult: A new insight. J Cell Tissue Res. 2020;20(1):6853–6860.
  6. Rao KS, Raja babu KK, Gupta PD. Keratins and skin disorders. Cell Biol I. 1996;(204):261–274.
  7. Wu RQ, Zhang DF, Tu E, et al. The mucosal immune system in the oral cavity—an orchestra of T cell diversity. Int J Oral Sci. 2014;6(3):125–132.
  8. Amsen D, Spilianakis CG, Flavell RA. How are TH1 and TH2 effector cells made? Curr Opin Immunol. 2009; 21(2):153–160.
  9. Brandtzaeg P, Pabst R. Let’s go mucosal: communication on slippery ground. Trends Immunol. 2004; 25(11):570–577.
  10. Konkel JE, Chen W. Balancing acts: the role of TGF-β in the mucosal immune system. Trends Mol Med. 2011;17(11):668–676.
  11. Ouyang W, Valdez P. IL-22 in mucosal immunity. Mucosal Immunol. 2008;1(5):335–338.
  12. Schluter J, Peled JU, Taylor BP, The gut microbiota is associated with immune cell dynamics in humans. Nature. 588(7837):303–307.
  13. Sawicka B, Kaid Johar SR, Sood PP, et al. Imbalance of Gut Microbiota Induces Cancer: A Review. J Cell Tissue Res. 2018;17(2):6073–6084.
  14. Sundararaman A, Ray M, Ravindra PV, et al. Role of probiotics to combat viral infections with emphasis on COVID-19. Appl Microbiol Biotechnol. 2020;104(19):1–16.
Creative Commons Attribution License

©2021 Gupta. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.